Lupin Limited is a transnational pharmaceutical Company. The Company is engaged in producing a range of generic and branded formulations and bulk drugs. It manufactures Active Pharmaceutical Ingredients (APIs) and several drug formulations. Its product basket consists of formulations from Cephalosporins, CVS, CNS, Anti-Asthma, Anti-TB, Diabetology, Dermatology, GI, and other therapy segments. Its APIs products include Cephalexin, Cefaclor, Cefadroxil, Cefprozil, Rifaximin, Ethambutol, Pyrazinamide, Rifampicin, Rifabutin, Lisinopril, Simvastatin, Prasugrel, Levetiracetam, Lacosamide, Eslicarbazepine Acetate, Rasagiline Mesylate, Pregabalin, Flupirtine Maleate and Febuxostat. As on March 31, 2012, the Company had 19 subsidiaries. During the year ended March 31, 2012, the Company, through its wholly owned subsidiary Lupin Holdings B.V., Netherlands (LHBV), acquired 100% interest in subsidiaries, which includes Hormosan Pharma GmbH, Lupin Philippines Inc. and Lupin Mexico SA de CV.